Tarsus Pharmaceuticals (TARS) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.37
-1.12
-0.86
-0.61

Details

Expected EPS
-0.939817
Actual EPS
-0.61
Surprise EPS
0.33
Surprise Percent
+35.09%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -0.61 per share for Q4 2024.

0 Comments

Share your thoughts